{"title":"Natural Bioactive Compounds Targeting Lipid Metabolism in Metabolic Dysfunction-Associated Steatotic Liver Disease.","authors":"Ji-Kai Ma, Jian-Fei Yang, Yu-Ping Ma, Bing-Qiang Chen, Sheng-Cai Li, Yu-Bei Lu, Zhong Xu, Yan-Long Li","doi":"10.1002/ptr.70525","DOIUrl":"https://doi.org/10.1002/ptr.70525","url":null,"abstract":"<p><p>Metabolic dysfunction-associated steatotic liver disease (MASLD) is a common chronic liver disease worldwide, with abnormal lipid accumulation in hepatocytes as its principal pathological alteration. Disruption of hepatic lipid homeostasis is associated with processes such as fatty acid uptake, de novo lipogenesis (DNL), fatty acid oxidation (FAO), lipid transport, and autophagy-lipophagy-mediated clearance, and it drives the onset and progression of MASLD. Although some drugs have been approved for patients with specific metabolic dysfunction-associated steatohepatitis (MASH) and moderate-to-severe fibrosis, therapeutic options that are broadly applicable across the full MASLD disease spectrum, particularly for patients with early steatosis, complex metabolic phenotypes, and multiple coexisting metabolic abnormalities, remain limited in terms of population coverage, long-term safety, and clearly defined therapeutic targets. In this article, relevant databases, including PubMed and the Web of Science Core Collection, were searched to include basic experimental and clinical studies related to lipid metabolism dysregulation and intervention with natural bioactive compounds within the MASLD/MASH disease spectrum, and the findings were organized according to molecular processes and clinical applications. The available evidence suggests that natural bioactive compounds may modulate hepatic lipid homeostasis by reducing fatty acid uptake and de novo lipogenesis, enhancing fatty acid oxidation, regulating lipid transport and export-related pathways, restoring autophagy-lipophagy-mediated lipid droplet clearance, and attenuating gut-liver axis dysregulation, oxidative stress, and inflammatory injury. From the perspective of lipid metabolism, this article summarizes the molecular processes, clinical evidence, and application barriers associated with natural bioactive compounds in the intervention of MASLD, with the aim of providing a basis for subsequent research on the prevention and treatment of MASLD using natural products.</p>","PeriodicalId":20110,"journal":{"name":"Phytotherapy Research","volume":" ","pages":""},"PeriodicalIF":8.1,"publicationDate":"2026-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149409517","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Astragaloside IV Mitigates Hepatocyte Apoptosis in Metabolic Dysfunction-Associated Fatty Liver Disease Through Inhibition of CASP3-Dependent PARP1 Cleavage.","authors":"Fengyi Zhang, Xinhe Wang, Yahui Li, Wenlu Ma, Yaxin Chen, Yufeng Zhang, Jiayi Zhang, Xin Wang, Jingjing Pan, Yu Zhang, Ziyang Cheng, Wenbo Wang, Yujie Li","doi":"10.1002/ptr.70473","DOIUrl":"https://doi.org/10.1002/ptr.70473","url":null,"abstract":"<p><p>Metabolic dysfunction-associated fatty liver disease (MAFLD) is associated with hepatic lipid accumulation, inflammation, and hepatocyte apoptosis. Astragaloside IV (AS-IV) has been reported to regulate lipid metabolism, but its effects on hepatocyte apoptosis in MAFLD remain unclear. We investigated the effects of AS-IV in db/db mice and free fatty acid (FFA)-treated HepG2 cells using biochemical assays, histological staining, measurements of inflammatory markers and reactive oxygen species, and apoptosis assays. Network pharmacology and molecular docking were used to identify candidate targets, followed by analyses of CASP3 and PARP1 expression and cleavage and CASP3 overexpression experiments. AS-IV reduced hepatic and cellular triglyceride accumulation, inflammatory markers, and hepatocyte apoptosis, and improved liver histology and serum markers of liver injury in db/db mice. These effects were accompanied by reduced CASP3 activation and PARP1 cleavage. In HepG2 cells, AS-IV also attenuated the changes associated with CASP3 overexpression. Together, these findings suggest that suppression of CASP3-associated PARP1 cleavage may contribute to the protective effects of AS-IV in these experimental models of MAFLD.</p>","PeriodicalId":20110,"journal":{"name":"Phytotherapy Research","volume":" ","pages":""},"PeriodicalIF":8.1,"publicationDate":"2026-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149409516","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Anubroto Pal, Sayani Banerjee, Lokesh Sharan, Ravindra Kumar, Neelanjan Chowdhury, Arka Das, S Sarath Babu, David Paul, Sugato Banerjee
{"title":"Urolithin A Modulates SIRT-1 Mediated Improvement of Mitochondrial Health in Experimental Model of Oxaliplatin Induced Peripheral Neuropathy.","authors":"Anubroto Pal, Sayani Banerjee, Lokesh Sharan, Ravindra Kumar, Neelanjan Chowdhury, Arka Das, S Sarath Babu, David Paul, Sugato Banerjee","doi":"10.1002/ptr.70506","DOIUrl":"https://doi.org/10.1002/ptr.70506","url":null,"abstract":"<p><p>Oxaliplatin-induced peripheral neuropathy (OIPN) is a major dose-limiting adverse reaction of chemotherapy. It is characterised by motor and sensory hypersensitivity, loss of myelinated nerve fibres, oxidative stress, mitochondrial dysfunction and neuroinflammation. Urolithin A, a bioactive gut metabolite of ellagitannins, is recognised for its ability to restore mitochondrial homeostasis. This study investigated the neuroprotective efficacy of urolithin A against experimental OIPN, focusing on its ability to simultaneously balance mitochondrial biogenesis and mitophagy. To study OIPN, male Sprague-Dawley rats were administered oxaliplatin (4 mg/kg) over a 4-week period, paired with concurrent oral doses of urolithin A (25 and 50 mg/kg). The animals were evaluated through behavioural assays (Von Frey, Hargreaves Plantar and Randall-Selitto, etc.) and functional tests measuring sensory and motor nerve conduction velocity. Oxidative stress markers (MDA and GSH) and mitochondrial dynamics, specifically biogenesis and mitophagy, were measured. In parallel, an in vitro study exposed Neuro2a cells to 50 μM of oxaliplatin, followed by urolithin A treatment (15 μM), to investigate its neuroprotective efficacy and underlying molecular mechanisms. Urolithin A significantly attenuated OIPN, alleviating thermal and mechanical hypersensitivity in behavioural assessments. It mitigated oxidative stress and mitochondrial dysfunction while promoting mitochondrial biogenesis via the SIRT1-mediated pathway both in vitro and in vivo. Simultaneously, urolithin A enhanced mitophagy by directly activating SIRT1-induced autophagy markers, leading to a marked reduction in inflammatory cytokine levels and eventual mitigation of neuropathic pain. Urolithin A protected against oxaliplatin-induced neurotoxicity in Neuro2a cells and reversed peripheral neuropathy in rats by restoring SIRT1-mediated mitochondrial biogenesis and mitophagy balance and maintaining mitochondrial health. These findings highlight urolithin A as a potential therapeutic candidate for OIPN.</p>","PeriodicalId":20110,"journal":{"name":"Phytotherapy Research","volume":" ","pages":""},"PeriodicalIF":8.1,"publicationDate":"2026-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149409519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"N-Trans Caffeoyltyramine Alleviates Ulcerative Colitis by Targeting FXR to Promote Epithelial Barrier Protection and M2 Macrophage Polarization.","authors":"Xianling Ning, Mo Chen, Minglu Zhu, Yichen Deng, Yuyao Yuan, Zhiqiang Lin, Yuxin Yin","doi":"10.1002/ptr.70520","DOIUrl":"https://doi.org/10.1002/ptr.70520","url":null,"abstract":"<p><strong>Background and aim: </strong>Ulcerative colitis (UC) remains a clinical challenge owing to the complex pathogenesis and lack of curative therapies. Although Cannabis sativa has been associated with alleviating inflammatory bowel disease, the specific active constituents and underlying mechanisms remain poorly defined. The present study aimed to systematically evaluate the anti-UC effects and mechanisms of two structurally related compounds from C. sativa extracts, N-trans caffeoyltyramine (NCT), and N-trans feruloyltyramine (NFT).</p><p><strong>Experimental procedure: </strong>We compared the therapeutic efficacy of NCT and NFT in an acute UC mice model, and investigated the underlying mechanisms using both colonic epithelial cells and macrophages. To validate the involvement of the nuclear receptor FXR, we performed genetic loss-of-function approaches to assess the impact on epithelial barrier integrity and macrophage polarization.</p><p><strong>Key results: </strong>NCT is proven superior to NFT in alleviating acute UC. Remarkably, NCT exerts therapeutic efficacy by coordinating two pivotal aspects of UC pathogenesis. It improves tight junction structural integrity through upregulation of tight junction proteins while simultaneously promoting a protective M2 macrophage polarization. Mechanistically, FXR was identified as a key mediator of the effects of NCT, contributing to both barrier enhancement and macrophage phenotype switching.</p><p><strong>Conclusions and implications: </strong>The results provide a molecular rationale for the anti-UC activity of C. sativa and suggest that NCT alleviates UC, at least in part through FXR-mediated pathways. These findings support further preclinical development of NCT as a potential therapeutic candidate for UC.</p>","PeriodicalId":20110,"journal":{"name":"Phytotherapy Research","volume":" ","pages":""},"PeriodicalIF":8.1,"publicationDate":"2026-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149409518","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Lu Chen, Mengzhen Wei, Qiong Zhang, Lei Jia, Zhihong Zheng, Rui Tan
{"title":"Natural Glycosides in Neurodegenerative Diseases: Multi-Target Mechanisms via the Gut-Brain Axis.","authors":"Lu Chen, Mengzhen Wei, Qiong Zhang, Lei Jia, Zhihong Zheng, Rui Tan","doi":"10.1002/ptr.70521","DOIUrl":"https://doi.org/10.1002/ptr.70521","url":null,"abstract":"<p><p>The multifactorial complexity of neurodegenerative diseases (NDs), including Alzheimer's and Parkinson's disease, limits the efficacy of single-target therapies. Natural glycosides exhibit promising neuroprotective potential, but their clinical translation is hindered by poor oral bioavailability and limited blood-brain barrier (BBB) penetration. The gut-brain axis offers a framework for understanding their potential biological effects beyond direct central exposure. This review explores the multi-target mechanisms of natural glycosides in NDs, focusing on their interactions with the gut-brain axis. A narrative literature search was conducted in PubMed, Web of Science, and ScienceDirect for studies published up to June 2026. Relevant literature on glycosides, NDs, gut microbiota, microbial biotransformation, pharmacokinetics, and neuroprotective mechanisms was critically reviewed. Natural glycosides may affect ND-related processes through gut-mediated and systemic/central mechanisms. Poorly absorbed glycosides can interact with intestinal microbiota, potentially modulating microbial composition, intestinal barrier integrity, and short-chain fatty acids (SCFAs) production. Microbial biotransformation may generate metabolites with altered physicochemical properties and systemic exposure, potentially enhancing central nervous system accessibility in a compound-specific manner. Experimental evidence also suggests effects on neuroinflammation, mitochondrial homeostasis, autophagy, and synaptic function. However, most findings remain preclinical, with limited direct human evidence. The gut-brain axis provides a valuable perspective for understanding the biological activities of natural glycosides despite their limited oral bioavailability and BBB penetration. Further pharmacokinetic studies, causal investigations of microbiota-mediated effects, and controlled clinical trials are needed to establish their therapeutic potential in NDs.</p>","PeriodicalId":20110,"journal":{"name":"Phytotherapy Research","volume":" ","pages":""},"PeriodicalIF":8.1,"publicationDate":"2026-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149387487","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mohamed Fared Shawky Mohamed, Ahmed Mohsen Kamal El-Sagheir, Jen Chin Lin, Ming-Kuem Lin, Yung-Luen Yu, Jung Chao
{"title":"Artificial Intelligence for Precision Phytomedicine: A Critical Review and the Patient-Product-Mechanism-Response (PPMR) Framework.","authors":"Mohamed Fared Shawky Mohamed, Ahmed Mohsen Kamal El-Sagheir, Jen Chin Lin, Ming-Kuem Lin, Yung-Luen Yu, Jung Chao","doi":"10.1002/ptr.70505","DOIUrl":"https://doi.org/10.1002/ptr.70505","url":null,"abstract":"<p><p>Plant-derived preparations remain widely used, yet their clinical application is constrained by multicomponent composition, batch-to-batch chemical variability, and complex pharmacokinetics, poorly characterized interactions, and marked interindividual variability in response. Artificial intelligence (AI) and computational pharmacology offer analytical tools suited to the high-dimensional data generated by phytomedicine, but enthusiasm has outpaced the supporting evidence. This critical narrative review evaluates AI applications across the phytomedicine pipeline, grading them by the strength and directness of evidence from computational prediction through in vitro, animal, observational, and randomized clinical studies. We organize the field around a Patient-Product-Mechanism-Response (PPMR) framework, arguing that meaningful personalization requires joint characterization of both the patient and the chemically variable botanical product. Current applications are most mature for botanical authentication, spectral annotation, quality assurance, and mechanism-informed hypothesis generation, whereas validated tools for patient stratification, individualized product and dose selection, and improved clinical outcomes remain limited. Rather than claiming efficacy gains, we present AI as a means to advance standardized, mechanism-informed, and testable phytomedicine, contingent on higher-quality data, prospective external validation, and regulatory alignment. The central finding is that none of the studies examined demonstrated a complete AI-guided personalized-phytomedicine pathway from joint patient-and-product characterization through a prospectively validated individualized response; precision phytomedicine should therefore be described as an emerging and hypothesis-generating research programme rather than an established clinical capability.</p>","PeriodicalId":20110,"journal":{"name":"Phytotherapy Research","volume":" ","pages":""},"PeriodicalIF":8.1,"publicationDate":"2026-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149394944","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Pristimerin Attenuates Fibrogenesis and Inflammation Through TIPE1-Regulated P2X7r Inflammatory Signaling Cascades in Hepatic Fibrosis.","authors":"Guan-Cheng Liu, Qi-Yuan Feng, Shuya Li, Yue Shang, Xin Guo, Hai-Ming Sun, Yu-Chen Jiang, Jian Song","doi":"10.1002/ptr.70502","DOIUrl":"https://doi.org/10.1002/ptr.70502","url":null,"abstract":"<p><p>Pristimerin (Pris), a natural triterpenoid extracted from Celastrus orbiculatus Thunb. and Gymnosporia acuminata Hook. f., has various pharmacological activities, including anti-inflammatory and anti-tumor effects. Our study explored the influence of Pris on fibrogenesis and inflammatory modulation via the tumor necrosis factor-alpha-induced protein 8-like 1 (TIPE1)-P2X7r axis in hepatic fibrosis. We induced a model of hepatic fibrosis in mice through intraperitoneal administration of Thioacetamide (TAA). To elucidate the pathways associated with fibrosis, RNA sequencing was performed. HSC-T6 cells were stimulated with transforming growth factor-β (TGF-β) while LX-2 cells were treated with siRNA targeting TIPE1. Bone marrow-derived macrophages (BMDMs) were exposed to a combination of lipopolysaccharide and adenosine triphosphate (LPS/ATP) along with Pris to produce conditioned medium. RNA sequencing data indicated significant alterations in pathways involving TIPE1, NOD-like receptors, and neutrophil extracellular traps (NETs) in the fibrosis context. Pris decreased accumulation of extracellular matrix (ECM) and the epithelial-mesenchymal transition (EMT) in the fibrotic liver. Pris significantly reduced the secretion of inflammatory mediators, NETs, and fibrosis markers. Pris activated TIPE1 while suppressing P2X7r and NLRP3 (NOD-like receptor family pyrin domain-containing protein 3) expression in activated HSCs and in TAA-challenged mice. Furthermore, Pris diminished ECM expression and reversed macrophage-induced activation of HSCs, supporting previous findings. The absence of TIPE1 impaired Pris's ability to inhibit P2X7r in LX-2 cells. Additionally, while LPS/ATP stimulation upregulates NLRP3, GSDMD, and IL-23 in mouse BMDMs, Pris exerts a notable inhibitory effect on these pyroptosis factors. Thus, our study demonstrates that Pris alleviates hepatic fibrosis by regulating the TIPE1-P2X7r axis. This finding not only positions Pris as a promising therapeutic candidate but, more importantly, highlights the critical role of the TIPE1-P2X7r axis in hepatic fibrosis, integrating purinergic P2X7r signaling, NLRP3 inflammasome activation, macrophage-HSC crosstalk, and NETs formation into an integrated mechanistic network.</p>","PeriodicalId":20110,"journal":{"name":"Phytotherapy Research","volume":" ","pages":""},"PeriodicalIF":8.1,"publicationDate":"2026-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149387488","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Galangin Exerts Neuroprotective Effects in Spinal Cord Injury by Targeting the PI3K/AKT and JAK2/STAT1 Pathways.","authors":"Shizhe Li, Shutao Gao, Yukun Hu, Weibin Sheng","doi":"10.1002/ptr.70509","DOIUrl":"https://doi.org/10.1002/ptr.70509","url":null,"abstract":"<p><p>Spinal cord injury (SCI) often leads to permanent neurological deficits, with no effective treatment currently available. Galangin is a naturally occurring flavonoid with anti-inflammatory and antiapoptotic activities; nevertheless, its efficacy, and molecular mechanisms in SCI remain unelucidated. First, network pharmacology and Gene Expression Omnibus database analyses were used to predict target molecules and galangin signaling pathways. In vitro, LPS-induced immortalized murine microglial (BV-2) and rat pheochromocytoma (PC12) cells co-cultured with conditioned medium were used to elucidate the mechanism via western blotting, immunofluorescence, qRT-PCR, ELISA, flow cytometry, cellular thermal shift assay (CETSA), drug affinity responsive target stability (DARTS), surface plasmon resonance (SPR), and pathway agonist/inhibitor/siRNA rescue assays. In vivo, SCI rat models were established to validate the protective efficacy through behavioral, histological, and western blot analyses. Galangin alleviated pro-inflammatory polarization and neuroinflammation in BV-2 microglia through inhibiting the PI3K/AKT pathway. It also diminished neuronal apoptosis and enhanced axonal growth-associated markers expression in PC12 neurons by inhibiting the JAK2/STAT1 pathway. These mechanisms were further supported experimentally using pathway agonists, inhibitors, and gene knockdown. In rats, galangin improved motor function and reduced neuroinflammation and neuronal damage. In conclusion, galangin simultaneously inhibited both pathways to alleviate neuroinflammation, decrease neuronal damage, and upregulate axonal growth-associated markers, thereby improving neurological function in SCI. Thus, galangin is a potential protective candidate for SCI.</p>","PeriodicalId":20110,"journal":{"name":"Phytotherapy Research","volume":" ","pages":""},"PeriodicalIF":8.1,"publicationDate":"2026-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149387485","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Luteolin Alleviates Renal Fibrosis in Diabetic Kidney Disease via Activation of the Cx32-Nrf2 Signaling Axis.","authors":"Shuang Liang, Qiudong Nong, Yeyi Chen, Yuan He, Ting Feng, Guitian Chen, Qingshao Zhang, Zhiying Liu, Guoqi Ou, Dezhe Tang, Yang Jiao, Zhiquan Chen","doi":"10.1002/ptr.70507","DOIUrl":"https://doi.org/10.1002/ptr.70507","url":null,"abstract":"<p><p>Luteolin (Lut) is a flavonoid found in many medicinal plants, and previous studies have shown that it can slow the progression of diabetic kidney disease (DKD), although the mechanism is incompletely defined. This study asked whether Lut protects against DKD by acting on the connexin32 (Cx32)-Nrf2 signaling axis to suppress ferroptosis and partial epithelial-mesenchymal transition (EMT). Renal fibrosis, oxidative stress, EMT, and ferroptosis related markers, as well as Cx32/Nrf2 expression were assessed in db/db mice and high glucose (HG)-induced NRK-52E cells. Microdissected human kidney transcriptomes were obtained from GEO and analyzed in R. Molecular docking and cellular thermal shift assay (CETSA) were used to test whether Lut interacts with Cx32. siRNA knockdown was used to test whether Cx32 is required for its effects. Lut improved renal function, reduced fibrosis, lowered ROS, EMT, and ferroptosis in db/db mice and HG-induced NRK-52E cells. Additionally, Cx32 and Nrf2 protein levels were reduced, which was restored by Lut treatment. And overexpression of Cx32 promoted Nrf2 nuclear translocation. In human diabetic kidney transcriptomes, Cx32 and Nrf2 transcripts changed reciprocally and were inversely correlated across two independent cohorts, supporting Cx32 as a candidate upstream node. Molecular docking indicated that Lut binds to the ARG22 and THR18 residues of Cx32, and CETSA showed that Lut increased the thermal stability of Cx32. Knockdown of Cx32 abolished Nrf2 activation by Lut. Therefore, we concluded that Lut attenuates renal fibrosis in DKD by activating the Cx32-Nrf2 signaling axis.</p>","PeriodicalId":20110,"journal":{"name":"Phytotherapy Research","volume":" ","pages":""},"PeriodicalIF":8.1,"publicationDate":"2026-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149387486","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Vahid Pourbarkhordar, Sohrab Rahmani, Hossein Hosseinzadeh, Soghra Mehri
{"title":"The Effect of Natural Compounds on Cognitive Impairment Through BDNF/TrkB/CREB Pathway: A Review.","authors":"Vahid Pourbarkhordar, Sohrab Rahmani, Hossein Hosseinzadeh, Soghra Mehri","doi":"10.1002/ptr.70517","DOIUrl":"https://doi.org/10.1002/ptr.70517","url":null,"abstract":"<p><p>Considering the global prevalence of Alzheimer's disease (AD) and the restrictions of current treatment procedures, natural compounds (such as curcumin, hesperidin, and rutin) have been evaluated as multifaceted therapeutic agents. This review demonstrated that these compounds employ neuroprotective effects primarily through upregulating the brain-derived neurotrophic factor/tropomyosin receptor kinase B/cAMP response element binding protein (BDNF/TrkB/CREB) pathway. After inducing this pathway, they subsequently decrease apoptosis through the regulation of B-cell lymphoma protein 2-associated X/B-cell lymphoma 2 protein (Bax/Bcl2) ratio and the inhibition of apoptosis signal-regulating kinase 1 (ASK1) (e.g., icariin). They also modulate oxidative stress via increasing superoxide dismutase, catalase, and glutathione peroxidase (e.g., hesperidin), and suppress neuroinflammation through the inhibition of nuclear factor kappa-light-chain-enhancer of activated B cells (Nf-κB) and proinflammatory cytokines (e.g., curcumin). These compounds enhance the level of postsynaptic density protein (PSD-95), a key enhancer of neuronal plasticity, improve synaptic signaling (e.g., oleanolic acid), and reduce cognitive disorders by reducing the formation of amyloid beta (Aβ) plaques (e.g., rutin). The phosphatidylinositol 3-kinase/protein kinase B (PI3K/Akt) signaling pathway is modulated (e.g., icariin), and cholinergic neurons are restored (e.g., maslinic acid). Despite the beneficial potential of natural compounds, the extrapolation of their findings to clinical application requires more precise preclinical studies and validated biomarkers.</p>","PeriodicalId":20110,"journal":{"name":"Phytotherapy Research","volume":" ","pages":""},"PeriodicalIF":8.1,"publicationDate":"2026-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149387489","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}